Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiency.

Li J, Pak SC, O'Reilly LP, Benson JA, Wang Y, Hidvegi T, Hale P, Dippold C, Ewing M, Silverman GA, Perlmutter DH.

PLoS One. 2014 Jan 31;9(1):e87260. doi: 10.1371/journal.pone.0087260. eCollection 2014.

2.

Effect of proximal box elevation with resin composite on marginal quality of resin composite inlays in vitro.

Roggendorf MJ, Krämer N, Dippold C, Vosen VE, Naumann M, Jablonski-Momeni A, Frankenberger R.

J Dent. 2012 Dec;40(12):1068-73. doi: 10.1016/j.jdent.2012.08.019. Epub 2012 Sep 7.

PMID:
22960537
3.

SPOC1 (PHF13) is required for spermatogonial stem cell differentiation and sustained spermatogenesis.

Bördlein A, Scherthan H, Nelkenbrecher C, Molter T, Bösl MR, Dippold C, Birke K, Kinkley S, Staege H, Will H, Winterpacht A.

J Cell Sci. 2011 Sep 15;124(Pt 18):3137-48. doi: 10.1242/jcs.085936. Epub 2011 Aug 18.

4.

An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.

Hidvegi T, Ewing M, Hale P, Dippold C, Beckett C, Kemp C, Maurice N, Mukherjee A, Goldbach C, Watkins S, Michalopoulos G, Perlmutter DH.

Science. 2010 Jul 9;329(5988):229-32. doi: 10.1126/science.1190354. Epub 2010 Jun 3.

5.

Brain lithium concentrations in bipolar disorder patients: preliminary (7)Li magnetic resonance studies at 3 T.

Soares JC, Boada F, Spencer S, Mallinger AG, Dippold CS, Wells KF, Frank E, Keshavan MS, Gershon S, Kupfer DJ.

Biol Psychiatry. 2001 Mar 1;49(5):437-43.

PMID:
11274655
6.

Increased platelet membrane phosphatidylinositol-4,5-bisphosphate in drug-free depressed bipolar patients.

Soares JC, Dippold CS, Wells KF, Frank E, Kupfer DJ, Mallinger AG.

Neurosci Lett. 2001 Feb 16;299(1-2):150-2.

PMID:
11166959
7.

Concurrent measures of protein kinase C and phosphoinositides in lithium-treated bipolar patients and healthy individuals: a preliminary study.

Soares JC, Chen G, Dippold CS, Wells KF, Frank E, Kupfer DJ, Manji HK, Mallinger AG.

Psychiatry Res. 2000 Aug 21;95(2):109-18.

PMID:
10963797
8.

Effects of lithium on platelet membrane phosphoinositides in bipolar disorder patients: a pilot study.

Soares JC, Mallinger AG, Dippold CS, Forster Wells K, Frank E, Kupfer DJ.

Psychopharmacology (Berl). 2000 Mar;149(1):12-6.

PMID:
10789877
9.

Reproducibility of in vivo measures of platelet membrane phospholipids in human subjects.

Soares JC, Dippold CS, Wells KF, Houck P, Mallinger AG.

Psychiatry Res. 1999 May 31;86(2):107-12.

PMID:
10397413
10.

Platelet membrane phospholipids in euthymic bipolar disorder patients: are they affected by lithium treatment?

Soares JC, Mallinger AG, Dippold CS, Frank E, Kupfer DJ.

Biol Psychiatry. 1999 Feb 15;45(4):453-7.

PMID:
10071717
11.

Low rate of membrane lithium transport during treatment correlates with outcome of maintenance pharmacotherapy in bipolar disorder.

Mallinger AG, Frank E, Thase ME, Dippold CS, Kupfer DJ.

Neuropsychopharmacology. 1997 May;16(5):325-32.

12.

Platelet membrane phosphatidylinositol-4,5-bisphosphate alterations in bipolar disorder--evidence from a single case study.

Soares JC, Dippold CS, Mallinger AG.

Psychiatry Res. 1997 Mar 24;69(2-3):197-202.

PMID:
9109187
13.

Erythrocyte membrane phospholipids in psychotic patients.

Keshavan MS, Mallinger AG, Pettegrew JW, Dippold C.

Psychiatry Res. 1993 Oct;49(1):89-95.

PMID:
8140184
14.
15.

Reduced cell membrane affinity for lithium ion during maintenance treatment of bipolar affective disorder.

Mallinger AG, Himmelhoch JM, Thase ME, Dippold C, Knopf S.

Biol Psychiatry. 1990 Apr 1;27(7):795-8. No abstract available.

PMID:
2109641

Supplemental Content

Loading ...
Support Center